Scabies
Overview
Scabies is a highly contagious skin infestation caused by Sarcoptes scabiei var. hominis, a parasitic mite in the class Arachnida. It affects over 100 million people worldwide annually across all ages, races, and socioeconomic levels. Prevalence in some developing countries ranges from 4% to 100% of the general population.
The Mite
- Appearance: Pearl-like, translucent, white, oval, eyeless, with 4 pairs of short stubby legs
- Size: Adult female is 0.4 × 0.3 mm (just barely invisible to the naked eye); male is slightly smaller
- Survival off the host: 3 days in a sterile environment; up to 7 days in mineral oil
- Cannot fly or jump
- A normal host harbors 3 to 50 female mites; infants and the elderly may harbor 50-250; patients with crusted scabies can harbor millions
Life Cycle
The entire life cycle occurs on human skin. The female mite burrows into the stratum corneum (to the boundary of the stratum granulosum), excavating 0.5-5 mm per day, laying 0-4 eggs/day (up to 50 eggs in her lifetime). Larvae hatch and complete development to adults on the skin surface.
Transmission
- Primary route: Close, prolonged skin-to-skin contact (sexual and non-sexual)
- Fomites: Much less likely in normal scabies but highly relevant in crusted scabies (mites shed in huge numbers into bedding, furniture, floors)
- Incubation period: 4-6 weeks in first exposure; only 1-4 days on re-exposure (due to sensitization)
Clinical Features
Symptoms
- Intense pruritus, classically worse at night (sensitization to mite saliva, eggs, feces)
- On re-infestation, symptoms begin within 1-4 days
Distribution (classic sites)
- Interdigital web spaces of fingers
- Volar wrists and lateral palms
- Elbows, axillae
- Scrotum, penis, labia, areolae in women
- Head and neck spared in healthy adults; involved in infants, the elderly, and immunocompromised
Lesions
- Small (<5 mm) papules, pustules, and vesicles with excoriations
- Pathognomonic sign: The burrow - a thin, thread-like, linear or J-shaped tunnel 1-10 mm long in the stratum corneum
Here is what the burrow and mite look like under dermoscopy:
Dermoscopy showing the "delta/triangle sign" - dense mite head (long red arrow), translucent body (long black arrow), eggs (short red arrows), and classic S-shaped burrow. (Fitzpatrick's Dermatology)
And burrows in the web spaces of fingers:
Thread-like burrows in the web spaces of the fingers - a classic location. (Fitzpatrick's Dermatology)
Crusted (Norwegian) Scabies
A severe variant in immunocompromised patients (HIV, elderly, dementia, neuropathy, leprosy):
- Hyperkeratotic plaques diffusely on palmar/plantar regions
- Thickening and dystrophy of toenails and fingernails
- Minimal or no pruritus (defective immune/sensory response)
- Millions of mites - extremely contagious; can spread to anyone in the vicinity
- Environmental mite burden is enormous (6,000 mites/g of shed debris from sheets, furniture)
Diagnosis
Clinical in most cases (history + characteristic distribution + pruritus worse at night).
Confirmatory tests:
- Skin scraping with a broad-blade scalpel from the terminal end of a burrow, placed in mineral oil on a glass slide - look for mites (330-450 μm), eggs, or scybala (fecal pellets). Low sensitivity.
- Dermoscopy (epiluminescence microscopy): Non-invasive; identifies the "delta-wing jet" or "triangle sign" of mite parts within the stratum corneum in vivo. Higher sensitivity.
- Burrow ink test: Apply black felt-tip marker to affected area, wipe off with alcohol - the burrow retains ink and becomes visible
- Reflectance confocal microscopy and PCR on swabbed skin are emerging high-sensitivity/specificity tools
Differential diagnosis: Atopic dermatitis, contact dermatitis, pityriasis rosea, papular urticaria, secondary syphilis, folliculitis, lichen planus, psoriasis, dermatitis herpetiformis
Treatment
First-line
| Agent | Regimen | Notes |
|---|
| Permethrin 5% cream | Apply neck-to-toe, leave on 8-14 hours, wash off; repeat in 1-2 weeks | Drug of choice; ovicidal; safe in pregnancy and infants >2 months |
| Oral ivermectin | 200 mcg/kg × 2 doses, 7-14 days apart | Not ovicidal - second dose essential; not FDA-approved for scabies; not established in <15 kg or pregnancy |
A Cochrane review found oral ivermectin is as effective as topical permethrin.
Crusted scabies
- Combination of oral ivermectin + topical permethrin is recommended (mite burden is too high for topical alone to be reliable)
Alternative agents
- Crotamiton 10% cream/lotion
- Precipitated sulfur 5-10% in petrolatum (safe in pregnancy and infants <2 months - youngest age group)
- Lindane 1% - avoid due to neurotoxicity; reserve only if all others fail or cannot be tolerated; contraindicated in children <10 years
Adjunct therapy
- Oral antihistamines and topical corticosteroids for pruritus relief (itching may persist for weeks after successful treatment due to ongoing hypersensitivity reaction)
- Topical/systemic antibiotics for secondary bacterial infection of excoriated lesions
Key Management Points
- Treat all contacts simultaneously - family members and close contacts, even if asymptomatic (many are asymptomatic mite carriers)
- Environment decontamination: Wash and dry all clothing, bedding, towels at high temperature; vacuum floors and furniture
- Pruritus persisting after treatment does not mean treatment failure - the hypersensitivity reaction can last weeks
- Hospitalized patients: Contact precautions until successfully treated
Sources: Fitzpatrick's Dermatology Vol 1-2; Rosen's Emergency Medicine; Red Book 2021 (Committee on Infectious Diseases); Goldman-Cecil Medicine International Edition